Development, validity and responsiveness of the Clinical COPD Questionnaire

<p>Abstract</p> <p>Background</p> <p>The new Global Obstructive Lung Disease (GOLD) guidelines advice to focus treatment in Chronic Obstructive Pulmonary Disease (COPD) on improvement of functional state, prevention of disease progression and minimization of symptoms. S...

Full description

Bibliographic Details
Main Authors: ten Hacken Nick HT, Schokker Siebrig, Willemse Brigitte WM, van der Molen Thys, Postma Dirkje S, Juniper Elizabeth F
Format: Article
Language:English
Published: BMC 2003-04-01
Series:Health and Quality of Life Outcomes
Online Access:http://www.hqlo.com/content/1/1/13
id doaj-f517c536dbcd473e9d518507fd7fc57e
record_format Article
spelling doaj-f517c536dbcd473e9d518507fd7fc57e2020-11-25T00:07:27ZengBMCHealth and Quality of Life Outcomes1477-75252003-04-01111310.1186/1477-7525-1-13Development, validity and responsiveness of the Clinical COPD Questionnaireten Hacken Nick HTSchokker SiebrigWillemse Brigitte WMvan der Molen ThysPostma Dirkje SJuniper Elizabeth F<p>Abstract</p> <p>Background</p> <p>The new Global Obstructive Lung Disease (GOLD) guidelines advice to focus treatment in Chronic Obstructive Pulmonary Disease (COPD) on improvement of functional state, prevention of disease progression and minimization of symptoms. So far no validated questionnaires are available to measure symptom and functional state in daily clinical practice. The aim of this study was to develop and validate the Clinical COPD Questionnaire (CCQ).</p> <p>Methods</p> <p>Qualitative research with patients and clinicians was performed to generate possible items to evaluate clinical COPD control. Thereafter, an item reduction questionnaire was sent to 77 international experts. Sixty-seven experts responded and the 10 most important items, divided into 3 domains (symptoms, functional and mental state) were included in the CCQ (scale: 0 = best, 6 = worst).</p> <p>Results</p> <p>Cross-sectional data were collected from 119 subjects (57 COPD, GOLD stage I-III; 18 GOLD stage 0 and 44 (ex)smokers). Cronbach's α was high (0.91). The CCQ scores in patients (GOLD 0-III) were significantly higher than in healthy (ex)smokers. Furthermore, significant correlations were found between the CCQ total score and domains of the SF-36 (ρ = 0.48 to ρ = 0.69) and the SGRQ (ρ = 0.67 to ρ = 0.72). In patients with COPD, the correlation between the CCQ and FEV<sub>1</sub>%pred was ρ =-0.49. Test-retest reliability was determined in 20 subjects in a 2-week interval (Intra Class Coefficient = 0.94). Thirty-six smokers with and without COPD showed significant improvement in the CCQ after 2 months smoking cessation, indicating the responsiveness of the CCQ.</p> <p>Conclusion</p> <p>The CCQ is a self-administered questionnaire specially developed to measure clinical control in patients with COPD. Data support the validity, reliability and responsiveness of this short and easy to administer questionnaire.</p> http://www.hqlo.com/content/1/1/13
collection DOAJ
language English
format Article
sources DOAJ
author ten Hacken Nick HT
Schokker Siebrig
Willemse Brigitte WM
van der Molen Thys
Postma Dirkje S
Juniper Elizabeth F
spellingShingle ten Hacken Nick HT
Schokker Siebrig
Willemse Brigitte WM
van der Molen Thys
Postma Dirkje S
Juniper Elizabeth F
Development, validity and responsiveness of the Clinical COPD Questionnaire
Health and Quality of Life Outcomes
author_facet ten Hacken Nick HT
Schokker Siebrig
Willemse Brigitte WM
van der Molen Thys
Postma Dirkje S
Juniper Elizabeth F
author_sort ten Hacken Nick HT
title Development, validity and responsiveness of the Clinical COPD Questionnaire
title_short Development, validity and responsiveness of the Clinical COPD Questionnaire
title_full Development, validity and responsiveness of the Clinical COPD Questionnaire
title_fullStr Development, validity and responsiveness of the Clinical COPD Questionnaire
title_full_unstemmed Development, validity and responsiveness of the Clinical COPD Questionnaire
title_sort development, validity and responsiveness of the clinical copd questionnaire
publisher BMC
series Health and Quality of Life Outcomes
issn 1477-7525
publishDate 2003-04-01
description <p>Abstract</p> <p>Background</p> <p>The new Global Obstructive Lung Disease (GOLD) guidelines advice to focus treatment in Chronic Obstructive Pulmonary Disease (COPD) on improvement of functional state, prevention of disease progression and minimization of symptoms. So far no validated questionnaires are available to measure symptom and functional state in daily clinical practice. The aim of this study was to develop and validate the Clinical COPD Questionnaire (CCQ).</p> <p>Methods</p> <p>Qualitative research with patients and clinicians was performed to generate possible items to evaluate clinical COPD control. Thereafter, an item reduction questionnaire was sent to 77 international experts. Sixty-seven experts responded and the 10 most important items, divided into 3 domains (symptoms, functional and mental state) were included in the CCQ (scale: 0 = best, 6 = worst).</p> <p>Results</p> <p>Cross-sectional data were collected from 119 subjects (57 COPD, GOLD stage I-III; 18 GOLD stage 0 and 44 (ex)smokers). Cronbach's α was high (0.91). The CCQ scores in patients (GOLD 0-III) were significantly higher than in healthy (ex)smokers. Furthermore, significant correlations were found between the CCQ total score and domains of the SF-36 (ρ = 0.48 to ρ = 0.69) and the SGRQ (ρ = 0.67 to ρ = 0.72). In patients with COPD, the correlation between the CCQ and FEV<sub>1</sub>%pred was ρ =-0.49. Test-retest reliability was determined in 20 subjects in a 2-week interval (Intra Class Coefficient = 0.94). Thirty-six smokers with and without COPD showed significant improvement in the CCQ after 2 months smoking cessation, indicating the responsiveness of the CCQ.</p> <p>Conclusion</p> <p>The CCQ is a self-administered questionnaire specially developed to measure clinical control in patients with COPD. Data support the validity, reliability and responsiveness of this short and easy to administer questionnaire.</p>
url http://www.hqlo.com/content/1/1/13
work_keys_str_mv AT tenhackennickht developmentvalidityandresponsivenessoftheclinicalcopdquestionnaire
AT schokkersiebrig developmentvalidityandresponsivenessoftheclinicalcopdquestionnaire
AT willemsebrigittewm developmentvalidityandresponsivenessoftheclinicalcopdquestionnaire
AT vandermolenthys developmentvalidityandresponsivenessoftheclinicalcopdquestionnaire
AT postmadirkjes developmentvalidityandresponsivenessoftheclinicalcopdquestionnaire
AT juniperelizabethf developmentvalidityandresponsivenessoftheclinicalcopdquestionnaire
_version_ 1725418053417566208